Schuurs–Hoeijmakers Syndrome (PACS1 Neurodevelopmental Disorder): Seven Novel Patients and a Review
Open Access
- 13 May 2021
- Vol. 12 (5), 738
- https://doi.org/10.3390/genes12050738
Abstract
Schuurs–Hoeijmakers syndrome (SHMS) or PACS1 Neurodevelopmental disorder is a rare disorder characterized by intellectual disability, abnormal craniofacial features and congenital malformations. SHMS is an autosomal dominant hereditary disease caused by pathogenic variants in the PACS1 gene. PACS1 is a trans-Golgi-membrane traffic regulator that directs protein cargo and several viral envelope proteins. It is upregulated during human embryonic brain development and has low expression after birth. So far, only 54 patients with SHMS have been reported. In this work, we report on seven new identified SHMS individuals with the classical c.607C > T: p.Arg206Trp PACS1 pathogenic variant and review clinical and molecular aspects of all the patients reported in the literature, providing a summary of clinical findings grouped as very frequent (≥75% of patients), frequent (50–74%), infrequent (26–49%) and rare (less than ≤25%).Funding Information
- Ministerio de Ciencia, Innovación y Universidades (BOCM-20181126-24)
This publication has 15 references indexed in Scilit:
- Schuurs‐Hoeijmakers syndrome in a patient from IndiaAmerican Journal of Medical Genetics Part A, 2019
- Schuurs‐Hoeijmakers syndrome in two patients from JapanAmerican Journal of Medical Genetics Part A, 2018
- Next-generation phenotyping using computer vision algorithms in rare genomic neurodevelopmental disordersGenetics in Medicine, 2018
- Mutation of PACS1: the milder end of the spectrumClinical Dysmorphology, 2018
- Ocular manifestations of PACS1 mutationJournal of American Association for Pediatric Ophthalmology and Strabismus, 2018
- A novel missense mutation affecting the same amino acid as the recurrent PACS1 mutation in Schuurs‐Hoeijmakers syndromeClinical Genetics, 2017
- Association of the missense variant p.Arg203Trp in PACS1 as a cause of intellectual disability and seizuresClinical Genetics, 2017
- Clinical delineation of the PACS1‐related syndrome—Report on 19 patientsAmerican Journal of Medical Genetics Part A, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Recurrent De Novo Mutations in PACS1 Cause Defective Cranial-Neural-Crest Migration and Define a Recognizable Intellectual-Disability SyndromeAmerican Journal of Human Genetics, 2012